Press release
Neoantigen Peptides Manufacturing Market Booms with Rising Demand for Personalized Cancer Vaccines and T-Cell Therapies
Neoantigen Peptides Manufacturing Market
According to the latest research by InsightAce Analytic, the global Neoantigen Peptides Manufacturing market is expected to grow with CAGR of 16.4% during the forecast period of 2025-2034.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1270
Neoantigen peptides, derived from tumor-specific somatic mutations, play a pivotal role in eliciting targeted immune responses against malignant cells. In the development of neoantigen-based vaccines, these personalized peptides are synthetically produced to promote T-cell activation. The immune system recognizes these peptides when T-cell receptors (TCRs) interact with human leukocyte antigen (HLA) molecules presenting the neoantigens. Neoantigens have emerged as a validated platform for cancer vaccine development, with ongoing investigations into various immunotherapeutic strategies aimed at treating diverse cancer types.
The neoantigen peptide manufacturing market is experiencing notable growth, underpinned by technological advancements in production algorithms that support the reliable synthesis of peptides for oncology research and pharmaceutical development. Market expansion is further supported by a rising number of successful clinical trials, the increasing global incidence of cancer and chronic illnesses, and the growing demand for innovative and sustainable treatment options. In addition, continued progress in biotechnology is expected to accelerate the development of personalized neoantigen-based therapies.
Increased investment in oncology research and development by both public and private entities also contributes to the market's upward trajectory. However, the market continues to face challenges, particularly the high cost associated with designing and producing individualized cancer treatments, as well as delays in clinical trial timelines-some of which were exacerbated by the COVID-19 pandemic.
Future growth opportunities lie in enhancing manufacturing efficiency, reducing associated costs, addressing existing treatment gaps, and fostering strategic collaborations among industry stakeholders. The integration of advanced data analytics is also anticipated to streamline therapeutic development and delivery. Regionally, North America is expected to maintain a leading position, driven by strong R&D activity, high cancer prevalence, and significant demand for cutting-edge therapeutic solutions, positioning it ahead of markets in Europe and Asia.
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04
Major key players operating in the neoantigen peptide manufacturing market are CPC Scientific Inc, Polypeptide group, Genscript Biotech, Kaneka Eurogentec S.A., Vivitide, Almac, BCN Peptides, Creative Peptides, Pepscan, Provepharm, Creosalus, Gyros Protein Technologies, Other Prominent Players.
Key Developments In The Market:
• In Mar 2022, Pepscan announced that its specialists would manufacture the personalized peptide pools to treat cancer patients in Evaxion's phase IIb trial. Evaxion Biotech, a clinical-stage biotechnology company, recently published the initial results of the peptide-based personalized therapy EVX-01 in patients with metastatic melanoma. Pepscan had provided the personalized peptide pools for its phase I/IIa trial.
• In January 2021, Genocea announced a cancer discovery publication. The advantages of neoantigen identification using the ATLAS platform and this discovery strengthens neoantigen immunotherapies by theoretically certifying that they target the correct neoantigens while removing Inhibigens.
• In Apr 2020, GenScript company announced the commercial launch of its neoantigen peptide synthesis service for personalized cancer therapeutics. GenScript partnered with several T-cell therapy and personalized cancer vaccine companies to develop the infrastructure for reliably manufacturing complex peptides for its neoantigen peptide synthesis platform.
• In Feb 2019, CPC Scientific Inc., a leading global CDMO specializing in synthetic peptide manufacturing, announced today that they would manufacture GMP-grade neoantigen peptides for investigators at UNC Lineberger Comprehensive Cancer Center (LCCC) for individualized immunotherapy. CPC Scientific will supply GMP-grade neoantigen peptides, the sequences of which will be determined via genomics and bioinformatics, for use in the LCCC therapeutic neoantigen vaccine program.
• In Jan 2019, Almac group (CDMO)added a second stream for high output GMP peptide manufacture to its facility in Edinburgh, Scotland. The site manufactures Neoantigen-derived peptides to produce its personalized cancer vaccines.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1270
Market Segments
Global Neoantigen Peptides Manufacturing Market, by Scale of operations, 2020-2030 (Value US$ Mn)
• Research/Preclinical
• Clinical
• Commercial
Global Neoantigen Peptides Manufacturing Market, by End-users 2020-2030 (Value US$ Mn)
• Pharmaceutical/Vaccine developers companies
• Contract Research Organizations (CRO)
• Academic and research institutes
Global Neoantigen Peptides Manufacturing Market, by Region, 2020-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Neoantigen Peptides Manufacturing Market, by Country, 2020-2030 (Value US$ Mn)
• U.S.
• Canada
Europe Neoantigen Peptides Manufacturing Market, by Country, 2020-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Neoantigen Peptides Manufacturing Market, by Country, 2020-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Neoantigen Peptides Manufacturing Market, by Country, 2020-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Neoantigen Peptides Manufacturing Market, by Country, 2020-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa
Read Overview Report- https://www.insightaceanalytic.com/report/global-neoantigen-peptides-manufacturing-market/1270
Why should buy this report:
• To receive a comprehensive analysis of the prospects for the global Neoantigen Peptides Manufacturing market
• To receive an industry overview and future trends of the Neoantigen Peptides Manufacturing market
• To analyze the Neoantigen Peptides Manufacturing market drivers and challenges
• To get information on the Neoantigen Peptides Manufacturing market size (Value US$ Mn) forecast to 2030
• Significant investments, mergers & acquisitions in the Neoantigen Peptides Manufacturing market industry
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neoantigen Peptides Manufacturing Market Booms with Rising Demand for Personalized Cancer Vaccines and T-Cell Therapies here
News-ID: 4104084 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Petcare IoT Platforms Market Surges with Wearables, Telemedicine Apps, and Conne …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Petcare IoT Platforms Market- by Pet Type (Dog, Cat, Fish, And Other Pet Types), Products (pet wearables [safety & security (GPS collars), Identification (smart tags), tracking (smart collars), behavior monitoring (bark collars), facilitation (temperature scanners, veterinarian appointments), medical diagnostics and treatment devices], connected pet products [Pet feeders & bowls, pet crates & beds, pet doors,…
Preclinical Oncology Models Market Grows at 10.9% CAGR, Boosted by Precision Can …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Preclinical Oncology Models Market- by Product (Patient-Derived Xenograft Models (PDX), Cell Line Derived Xenograft Models, Syngeneic Models, Genetically engineered mouse models (GEMMs), Orthotopic Models, Custom Xenograft and Syngeneic Model and Others), Application (Neuroblastoma, Prostate Cancer, Pancreatic Cancer, Breast Cancer, Colorectal Cancer, Bladder Cancer, Fibrosarcoma, Kidney Cancer, Liver Cancer, Lung Cancer, Lymphoma, Skin Cancer and Others),…
Immuno-Oncology Cell Therapy Market to Reach $95.3 Billion by 2034, Fueled by CA …
InsightAce Analytic Pvt. Ltd. announces the release of the market assessment report on "Global Immuno-Oncology Cell Therapy Market Therapy Type (CAR-T Cells, NK & NKT Cells, TAA/TSA targeted T Cell, TCR T Cell, Cytokine-induced killer cells, Dendritic cells, Macrophages, and Other Cell Therapies), Major Indication (Head & Neck Cancer, Lung Cancer, Kidney Cancer, Melanoma, Lymphoma, Leukemia, and Others) - Technology Trends, Clinical Trial/Pipeline Analysis, Revenue and Forecast Till 2034."
According…
Kombucha Market Key Players Analysis - Buchi Kombucha, Cell - Nique Corporation, …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Kombucha Market- by Flavor (Regular/Original, Herbs & Spices, Citrus, Berries, Apple, Coconut & Mangoes, Flowers, and Others), Distribution Channel (Food and Drink Specialty Store, Hypermarket/Supermarket, Convenience Store, and Online Retail), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic, the global Kombucha market is valued at US$ 3.27…
More Releases for Neoantigen
Neoantigen Vaccine Market Demands, Trend, Size, Share and Key Players Pfizer, Me …
Neoantigen Vaccine Market is an outstanding market research report that conducts industry analysis on products, markets, companies, industries, and many countries worldwide. When it is about guessing general market conditions, the growth prospects in the market, likely restrictions, significant industry trends, market size, market share, sales volume, and future trends, the finest market research report such as this Neoantigen Vaccine Market report comes into picture. The competitive analysis carried out…
North America to Dominate Neoantigen Cancer Vaccine Market through 2026 | TechSc …
Rising prevalence of cancer and increasing adoption of personalized medicine to drive the growth of global neoantigen cancer vaccine market.
According to TechSci Research report, “Global Neoantigen Cancer Vaccine Market By Product (Personalized neoantigen vaccine, Off-the shelf neoantigen vaccine), By Neoantigen Type (Synthetic long peptide (SLP), Nucleic Acid, Dendritic Cell, Tumor Cell), By Route of Administration (Intravenous, Intramuscular, Transdermal, Others), By Cell (Autologous, Allogenic), By Technology (RNA sequencing, Whole genome sequencing,…
Neoantigen Targeted Therapies Market Revenue, Industry Growing Demand, Size, Sha …
Neoantigen Targeted Therapies Market is thoroughly, accurate and comprehensively assessed in a report focusing on market dynamics, market competition, regional growth, segment analysis, and key growth strategies. Report buyers will have access to proven market figures including global market size in terms of revenue and volume.
(Get 15% Discount on Buying this Report)
A full report of Global Neoantigen Targeted Therapies Market is available at: https://www.orionmarketreports.com/neoantigen-targeted-therapies-market/56731/
The Neoantigen Targeted Therapies key players in…
Neoantigen targeted therapies market projected to reach USD 3 Billion by 2030, g …
Advances in bioinformatics and genomic data analysis have enabled the identification of cancer antigens that are generally overlooked during immune surveillance; these neoantigens have been shown to possess substantial therapeutic potential
London
Roots Analysis has announced the addition of “Neoantigen Targeted Therapies, 2019-2030” report to its list of offerings.
The use of neoantigens in therapy has demonstrated the ability to elicit a strong T cell mediated immune response. Several therapy candidates are…
2020-2025 Neoantigen Targeted Therapies Market to witness astonishing growth wit …
Global Neoantigen Targeted Therapies Market Synopsis:
The report covers a forecast and an analysis of the Neoantigen Targeted Therapies Market on a global and regional level. The study provides historical data for 2015, 2016, 2017 and 2018 along with a forecast from 2020 to 2025 based on revenue (USD Million) and volume (Kilotons). The study includes drivers and restraints of the Neoantigen Targeted Therapies Market along with the impact they have…
Neoantigen Targeted Therapies Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Neoantigen Targeted Therapies Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Neoantigen Targeted Therapies players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Neoantigen Targeted Therapies with respect…
